Found: 14
Select item for more details and to access through your institution.
HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival.
- Published in:
- Scientific Reports, 2016, p. 31154, doi. 10.1038/srep31154
- By:
- Publication type:
- Article
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma.
- Published in:
- Scientific Reports, 2016, p. 30093, doi. 10.1038/srep30093
- By:
- Publication type:
- Article
Insulin-Like Growth Factor 1 Receptor and Response to Anti-IGF1R Antibody Therapy in Osteosarcoma.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0106249
- By:
- Publication type:
- Article
ß-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
ß-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells.
- Published in:
- Sarcoma, 2012, p. 1, doi. 10.1155/2012/164803
- By:
- Publication type:
- Article
Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Preclinical activity of palifosfamide lysine (ZIO-201) in pediatric sarcomas including oxazaphosphorine-resistant osteosarcoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 4, p. 733, doi. 10.1007/s00280-008-0922-4
- By:
- Publication type:
- Article
The effect of bone morphogenetic protein-2 on osteosarcoma metastasis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0173322
- By:
- Publication type:
- Article
Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 9, p. 1558, doi. 10.1002/pbc.25074
- By:
- Publication type:
- Article
Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 4, p. 548, doi. 10.1002/cncr.28461
- By:
- Publication type:
- Article
Cell surface receptor expression patterns in osteosarcoma.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 3, p. 740, doi. 10.1002/cncr.26339
- By:
- Publication type:
- Article
Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32428-9
- By:
- Publication type:
- Article
A RUNX2-Mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells.
- Published in:
- PLoS Genetics, 2016, v. 12, n. 2, p. 1, doi. 10.1371/journal.pgen.1005884
- By:
- Publication type:
- Article